Streetbeat News

Stock Prices

ACLS

Axcelis Technologies (NASDAQ:ACLS) reported Q4 earnings with an EPS of $2.15, beating estimates by 6.44% and showing a revenue increase of $44.24 million from the previous year. The company has consistently beaten EPS estimates over the past four quarters, with share price reacting positively to past earnings announcements.

Portfolio Pulse from Benzinga Insights

February 07, 2024 | 9:05 pm

BARK

BARK (NYSE:BARK) reported its Q3 earnings with an EPS of $-0.05, matching estimates. Revenue decreased by $9.26 million compared to the same period last year. Despite matching EPS estimates this quarter, BARK's share price dropped 10.5% the day after last quarter's earnings beat.

Portfolio Pulse from Benzinga Insights

February 07, 2024 | 9:05 pm

MPWR

Monolithic Power Systems (NASDAQ:MPWR) reported Q4 earnings with an EPS of $2.88, beating estimates by 1.05% but with a revenue decrease of $6.00 million from the previous year. The company has a history of surpassing EPS estimates, which previously led to a 9.34% share price increase the following day.

Portfolio Pulse from Benzinga Insights

February 07, 2024 | 9:05 pm

VNDA

Vanda Pharma (NASDAQ:VNDA) reported Q4 earnings, beating estimates with an EPS of $-0.04 against an expected $-0.09. However, revenue decreased by $19.21 million from the previous year. Despite beating last quarter's EPS estimates, the share price dropped by 21.94% the following day.

Portfolio Pulse from Benzinga Insights

February 07, 2024 | 9:05 pm

BLBD

Blue Bird (NASDAQ:BLBD) reported Q1 earnings with an EPS of $0.91, beating estimates by 145.95% against an expected $0.37. Revenue increased by $81.93 million from the same period last year. The company's past earnings performance shows consistent beats on EPS estimates, with the last quarter resulting in a 10.45% share price increase the following day.

Portfolio Pulse from Benzinga Insights

February 07, 2024 | 9:05 pm

CSGS

CSG Systems Intl (NASDAQ:CSGS) reported Q4 2023 adjusted EPS of $0.92, surpassing the $0.86 estimate, and sales of $297.32M, exceeding the $281.16M estimate. This represents a 9.52% increase in EPS and a 2.57% increase in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 9:05 pm

FORM

FormFactor (NASDAQ:FORM) reported Q4 earnings with an EPS of $0.2, missing the estimated $0.22 by 9.09%. Revenue increased by $2.18 million from the same period last year. Despite beating EPS estimates in Q3 2023, the share price dropped by 0.93% the following day. The company's past earnings performance shows a pattern of fluctuating EPS and revenue figures.

Portfolio Pulse from Benzinga Insights

February 07, 2024 | 9:05 pm

FORM

FormFactor (NASDAQ:FORM) reported Q4 2023 earnings of $0.20 per share, missing the consensus estimate of $0.22. However, their sales of $168.16M exceeded the estimate of $165.29M, marking a 1.31% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 9:05 pm

VNDA

Vanda Pharma (NASDAQ:VNDA) reported Q4 2023 earnings with a GAAP EPS of $(0.04), surpassing the $(0.09) estimate. Sales reached $45.27M, exceeding the $37.00M forecast but marking a 29.79% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 9:04 pm

RRR

Red Rock Resorts (NASDAQ:RRR) reported Q4 2023 earnings of $0.95 per share, surpassing the $0.57 estimate by 66.67%. Quarterly sales reached $462.71M, exceeding the $439.64M estimate by 5.25% and marking an 8.75% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 9:03 pm